Biotron (ASX:BIT)
ASX announcement history & article coverage
Transparent by design.
Announcments by Biotron (ASX:BIT) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Director Appointment Michael Thurn & Appendix 3X
Appointment of CEO and Executive Director
Biotron appoints Glenn Gilbert as CEO and Executive Director
Resignation of Managing Director and Appendix 3Z
Biotron CEO Dr Michelle Miller resigns after 24 years as Board starts leadership search
Change of Share Registry
Investor Presentation
Appendix 4G
Corporate Governance Statement
Full Year Statutory Accounts and Appendix 4E
Biotron reports $1.52M loss, completes Sedarex acquisition, advances SedRxTM and antiviral programs
Change in substantial holding
HBV Treatment to Progress Towards Human Trials
Quarterly Activities/Appendix 4C Cash Flow Report
Biotron advances SedRx regulatory pathway and antiviral research, appoints new Chairman
